Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John MacDonald

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Journal of Hazardous Materials|March 15, 2025
Bioremediation of multiple heavy metals through biostimulation of microbial-induced calcite precipitation at varying calcium-to-urea concentrationsCarla Comadran-Casas, Cise Unluer, Adrian M Bass, et al.
Photochemistry and Photobiology|November 24, 2021
Probing the Ni<sup>2+</sup> -selective Response of Fluorescent Probe NiSensor-1 with the NiCast Photocaged ComplexErin E Hickey, Daniel P Kennedy, Celina Gwizdala, et al.
Surgery|January 2, 2017
Does prophylactic mesh placement in elective, midline laparotomy reduce the incidence of incisional hernia? A systematic review and meta-analysisZachary M Borab, Sameer Shakir, Michael A Lanni, et al.
Research Square|March 30, 2023
Cancer-derived mutation in the OGA stalk domain promotes cell malignancy through dysregulating PDLIM7 and p53Chia-Wei Hu, Ao Wang, Dacheng Fan, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2024
OGA mutant aberrantly hydrolyzes O-GlcNAc modification from PDLIM7 to modulate p53 and cytoskeleton in promoting cancer cell malignancyChia-Wei Hu, Ao Wang, Dacheng Fan, et al.
Clinical Colorectal Cancer|December 17, 2005
Phase I/II dose-escalation study of pemetrexed plus irinotecan in patients with advanced colorectal cancerHoward Hochster, Erika Kettner, Hendrik Kroning, et al.
JMIR Research Protocols|April 22, 2017
Mobile Application to Promote Adherence to Oral Chemotherapy and Symptom Management: A Protocol for Design and DevelopmentJoel Nathan Fishbein, Lauren Ellen Nisotel, James John MacDonald, et al.
Endoscopy International Open|June 21, 2024
Endoscopic scoring indices for assessing disease severity in familial adenomatous polyposis: Systematic reviewAnna Lerman Silverman, Hicham Bouchiba, Arthur Aelvoet, et al.
Cancer Chemotherapy and Pharmacology|May 23, 2007
A phase II study of milataxel: a novel taxane analogue in previously treated patients with advanced colorectal cancerRamesh K Ramanathan, Joel Picus, Haralambos Raftopoulos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2008
Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704Adam C Berger, Miguel Garcia, John P Hoffman, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Journal of Hazardous Materials|March 15, 2025
Bioremediation of multiple heavy metals through biostimulation of microbial-induced calcite precipitation at varying calcium-to-urea concentrationsCarla Comadran-Casas, Cise Unluer, Adrian M Bass, et al.
Photochemistry and Photobiology|November 24, 2021
Probing the Ni<sup>2+</sup> -selective Response of Fluorescent Probe NiSensor-1 with the NiCast Photocaged ComplexErin E Hickey, Daniel P Kennedy, Celina Gwizdala, et al.
Surgery|January 2, 2017
Does prophylactic mesh placement in elective, midline laparotomy reduce the incidence of incisional hernia? A systematic review and meta-analysisZachary M Borab, Sameer Shakir, Michael A Lanni, et al.
Research Square|March 30, 2023
Cancer-derived mutation in the OGA stalk domain promotes cell malignancy through dysregulating PDLIM7 and p53Chia-Wei Hu, Ao Wang, Dacheng Fan, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2024
OGA mutant aberrantly hydrolyzes O-GlcNAc modification from PDLIM7 to modulate p53 and cytoskeleton in promoting cancer cell malignancyChia-Wei Hu, Ao Wang, Dacheng Fan, et al.
Clinical Colorectal Cancer|December 17, 2005
Phase I/II dose-escalation study of pemetrexed plus irinotecan in patients with advanced colorectal cancerHoward Hochster, Erika Kettner, Hendrik Kroning, et al.
JMIR Research Protocols|April 22, 2017
Mobile Application to Promote Adherence to Oral Chemotherapy and Symptom Management: A Protocol for Design and DevelopmentJoel Nathan Fishbein, Lauren Ellen Nisotel, James John MacDonald, et al.
Endoscopy International Open|June 21, 2024
Endoscopic scoring indices for assessing disease severity in familial adenomatous polyposis: Systematic reviewAnna Lerman Silverman, Hicham Bouchiba, Arthur Aelvoet, et al.
Cancer Chemotherapy and Pharmacology|May 23, 2007
A phase II study of milataxel: a novel taxane analogue in previously treated patients with advanced colorectal cancerRamesh K Ramanathan, Joel Picus, Haralambos Raftopoulos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2008
Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704Adam C Berger, Miguel Garcia, John P Hoffman, et al.
Pageof 8